Skip to content

SYNERGY™ XD H7493941824500Recalls & reported problems

Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant

All models of SYNERGY XD (65)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729981275), received between Mar 12, 2021 and Feb 23, 2024 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Difficult to Remove” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult to Remove2
  • Break1
  • Defective Device1
  • Device Dislodged or Dislocated1
  • Difficult to Advance1
  • Failure to Advance1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 23, 2024Break; Difficult to Remove; Break; Difficult to Remove

    IT WAS REPORTED THAT REMOVAL DIFFICULTY AND SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN THE NON-TORTUOUS AND NON-CALCIFIED LEFT MAIN CORONARY ARTERY. A 5.00 X 24MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. THE BALLOON WAS INFLATED TO APPROXIMATELY 12 ATM AND THE STENT WAS IMPLANTED WITHOUT DIFFICULTY. DURING REMOVAL AND AFTER BALLOON DEFLATION, RESISTANCE WAS NOTICED WHEN REMOVING, AND THE BALLOON BECAME LODGED WITHIN THE STENT. AT THE SECOND ATTEMPT, THE STENT BALLOON WAS SUCCESSFULLY PULLED INTO THE GUIDE CATHETER, BUT THE STENT DELIVERY SHAFT FRACTURED AND BROKE APART NEAR THE MONORAIL WIRE EXIT PORT WITHIN THE GUIDE CATHETER. THE DETACHED PORTION OF THE DEVICE WAS REMOVED INSIDE THE GUIDE CATHETER FROM THE PATIENT. IT WAS NOTED THAT VACUUM WAS APPLIED AND HELD DURING BALLOON WITHDRAWAL. PHYSICAL DAMAGE WAS OBSERVED POST-PROCEDURE, AND THE BALLOON WAS DEFLATED PRIOR TO REMOVAL. THE PROCEDURE WAS COMPLETED WITH THE ORIGINAL DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18773358 ↗
  • InjuryOct 18, 2023Device Dislodged or Dislocated; Device Dislodged or Dislocated

    IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. A 5.00 X 24MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, DURING INSERTION OF THE DEVICE, THE STENT DETACHED FROM THE BALLOON INSIDE THE PATIENT. THE DEVICE WAS REMOVED SUCCESSFULLY AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS NOR INJURIES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17958069 ↗
  • MalfunctionMar 12, 2021Difficult to Remove; Failure to Advance; Defective Device; Difficult to Advance; Difficult to Remove; Failure to Advance; Defective Device; Difficult to Advance

    IT WAS REPORTED THAT DIFFICULTY REMOVAL WERE ENCOUNTERED. THE TARGET LESION WAS LOCATED IN THE RIGHT CORONARY ARTERY (RCA). A 5.00 X 24MM SYNERGY XD DRUG ELUTING STENT WAS SELECTED FOR USE. THE SYNERGY XD DRUG ELUTING STENT WAS ADVANCED BUT COULD NOT CROSS THE LESION. UPON REMOVAL THE SYNERGY XD DRUG ELUTING STENT, THE STENT WAS CATCHING ON THE CATHETER. IT WAS OBSERVED THAT THE BALLOON WAS SLIGHTLY INFLATED ON EACH END OF THE STENT. THE PROCEDURE WAS COMPLETED WITH A NON-BSC STENT. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11474135 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page